Global Antibody Drug Conjugates (ADCs) Market Size & Trends Report Segmented by Product (Kadcyla, Padcev, Enhertu, Adcetris, Trodelvy), Application (Breast Cancer, Blood Cancer), Target (HER2, CD22, CD30), Technology & Regional Forecasts to 2030

Global Antibody Drug Conjugates (ADCs) Market Segmentation

This report by Medi-Tech Insights provides thesize of the global antibody drug conjugates (ADCs) market at theregional- and country-level from 2023 to 2030. The report further segments the market based on product, application, target, and technology.

Market Size & Forecast (2023-2030), By Product, USD Million

• Kadcyla
• Enhertu
• Adcetris
• Padcev
• Trodelvy
• Polivy
• Others

Market Size & Forecast (2023-2030), By Application, USD Million

• Breast Cancer
• Blood Cancer
• Other Cancers

Market Size & Forecast (2023-2030), By Target, USD Million

• HER2
• CD22
• CD30
• Others

Market Size & Forecast (2023-2logy USD Million

• Linker Type
• Cleavable Linker
• Non-cleavable Linker
• Linker less
• Payload Technology
• MMAE/ Auristatin
• Maytansinoids
• Camptothecin
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa